| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |